Arrowhead Pharmaceuticals Inc (ARWR) — Tangible Net Worth Ratio
Arrowhead Pharmaceuticals Inc (ARWR) has a Tangible Net Worth Ratio of 98.6% as of September 2025. This metric is calculated by deducting intangible assets ($6.86 Million) from net assets ($503.42 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Arrowhead Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Arrowhead Pharmaceuticals Inc Tangible Net Worth Ratio (2003–2025)
This chart shows how Arrowhead Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 23 annual periods from 2003 to 2025. As of September 2025, the ratio stands at 98.6%, reflecting net assets of $503.42 Million with intangible assets of $6.86 Million USD. See ARWR days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Arrowhead Pharmaceuticals Inc (2003–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Arrowhead Pharmaceuticals Inc from 2003 to 2025, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Arrowhead Pharmaceuticals Inc worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.6% | $503.42 Million | $6.86 Million | $1.45 Billion | ▲ +3.1 pp |
| 2024 | 95.5% | $191.06 Million | $8.56 Million | $1.14 Billion | ▼ -0.9 pp |
| 2023 | 96.4% | $287.16 Million | $10.26 Million | $765.55 Million | ▼ -0.7 pp |
| 2022 | 97.1% | $418.34 Million | $11.96 Million | $691.94 Million | ▲ +0.5 pp |
| 2021 | 96.7% | $408.82 Million | $13.66 Million | $710.15 Million | ▼ 0.0 pp |
| 2020 | 96.7% | $461.78 Million | $15.36 Million | $522.50 Million | ▲ +3.7 pp |
| 2019 | 93.0% | $244.04 Million | $17.06 Million | $349.85 Million | ▲ +12.7 pp |
| 2018 | 80.3% | $95.24 Million | $18.76 Million | $111.61 Million | ▲ +5.6 pp |
| 2017 | 74.7% | $80.87 Million | $20.46 Million | $104.02 Million | ▼ -2.0 pp |
| 2016 | 76.7% | $95.02 Million | $22.16 Million | $128.18 Million | ▼ -0.7 pp |
| 2015 | 77.4% | $109.62 Million | $24.82 Million | $132.27 Million | ▼ -22.0 pp |
| 2014 | 99.4% | $165.99 Million | $1.01 Million | $182.82 Million | ▲ +12.0 pp |
| 2013 | 87.4% | $25.73 Million | $3.24 Million | $37.33 Million | ▲ +41.7 pp |
| 2012 | 45.7% | $8.81 Million | $4.78 Million | $16.53 Million | ▼ -40.5 pp |
| 2011 | 86.2% | $12.56 Million | $1.73 Million | $15.89 Million | ▲ +11.6 pp |
| 2010 | 74.7% | $8.08 Million | $2.05 Million | $12.35 Million | ▲ +23.3 pp |
| 2009 | 51.4% | $4.86 Million | $2.36 Million | $7.70 Million | ▼ -26.3 pp |
| 2008 | 77.7% | $12.30 Million | $2.75 Million | $17.26 Million | ▼ -11.2 pp |
| 2007 | 88.9% | $26.46 Million | $2.94 Million | $29.85 Million | ▼ -0.5 pp |
| 2006 | 89.4% | $31.61 Million | $3.35 Million | $34.53 Million | ▲ +1.1 pp |
| 2005 | 88.3% | $28.02 Million | $3.28 Million | $29.04 Million | ▼ -2.2 pp |
| 2004 | 90.5% | $11.23 Million | $1.06 Million | $11.92 Million | ▼ -9.5 pp |
| 2003 | 100.0% | $1.42 Million | $0.00 | $1.52 Million | — |